Tyber Medical Acquires FDA Clearance for Proximal Tibia Plating System
BETHLEHEM, Pa., Feb. 12, 2024 /PRNewswire/ -- Tyber Medical LLC, a leading orthopedic device manufacturer providing private label orthopedic implants for the trauma, extremity, and spine markets, has received a U.S. Food and Drug Administration (FDA) 510(k) approval for its Proximal Tibia Plating System. The Tyber Medical System consists of two indication categories: Complete Articular and Partial Articular Fractures. Both designs stabilize bone fragments to facilitate highly focused and efficient healing of a wide array of injuries to the tibia, fibula, and femur. "This innovative addition to the Tyber Medical portfolio aligns to meet the needs of our customers by offering multiple solutions to challenging anatomy," commented David Hannah, Chief Technology Officer at Tyber Medical. Mr. Hannah added. "This comprehensive system offers anatomic plating to support a wide range of trauma needs."
- BETHLEHEM, Pa., Feb. 12, 2024 /PRNewswire/ -- Tyber Medical LLC, a leading orthopedic device manufacturer providing private label orthopedic implants for the trauma, extremity, and spine markets, has received a U.S. Food and Drug Administration (FDA) 510(k) approval for its Proximal Tibia Plating System.
- The Tyber Medical System consists of two indication categories: Complete Articular and Partial Articular Fractures.
- The Tyber Medical Proximal Tibial Plating System is engineered to accommodate surgeon preferences, increase procedural efficiency, and enhance plate fit and screw placement.
- Lisa Boyle, Director of Regulatory Affairs commented "With the clearance of the Proximal Tibial Plating System and its sub-categories, Tyber Medical remains unwavering in our commitment to providing cutting edge orthopedic solutions."